ACTA NEUROLOGICA SCANDINAVICA Q2区

期刊简介

Acta Neurologica Scandinavica aims to publish manuscripts of a high scientific quality representing original clinical, diagnostic or experimental work in neuroscience. The journal's scope is to act as an international forum for the dissemination of information advancing the science or practice of this subject area. Papers in English will be welcomed, especially those which bring new knowledge and observations from the application of therapies or techniques in the combating of a broad spectrum of neurological disease and neurodegenerative disorders. Relevant articles on the basic neurosciences will be published where they extend present understanding of such disorders. Priority will be given to review of topical subjects. Papers requiring rapid publication because of their significance and timeliness will be included as 'Clinical commentaries' not exceeding two printed pages, as will 'Clinical commentaries' of sufficient general interest. Debate within the speciality is encouraged in the form of 'Letters to the editor'. All submitted manuscripts falling within the overall scope of the journal will be assessed by suitably qualified referees.

《斯堪的纳维亚神经学学报》旨在出版代表神经科学原始临床、诊断或实验工作的高科学质量的手稿。该杂志的范围是作为一个国际论坛，传播信息，促进科学或实践的这一主题领域。欢迎发表英语论文，特别是那些从治疗或技术应用中带来新知识和观察结果的论文，这些治疗或技术应用于对抗广泛的神经系统疾病和神经退行性疾病。基础神经科学的相关文章将发表，它们扩展了目前对这类疾病的理解。将优先审查专题。由于其重要性和及时性而需要迅速发表的论文将被列为“临床评论”，不超过两页，具有足够普遍意义的“临床评论”也将被列为“临床评论”。鼓励以“给编辑的信”的形式进行专业内的辩论。所有在期刊总体范围内提交的稿件将由具有适当资格的审稿人进行评估。

《ACTA NEUROLOGICA SCANDINAVICA》期刊已被查看： 次

期刊官网投稿信息

分区信息

• 上一篇： AUSTRALIAN HISTORICAL STUDIES
• 下一篇：Cancer Prevention Research